+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fecal Occult Testing Market - Global Forecast 2026-2032- Product Image
Fecal Occult Testing Market - Global Forecast 2026-2032- Product Image
Sale

Fecal Occult Testing Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904589
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fecal Occult Testing Market is projected to reach USD 918.36 Million in 2026. It is expected to continue growing at a CAGR of 8.16%, reaching USD 1.47 Billion by 2032.

Fecal occult testing remains a foundational, noninvasive approach for colorectal cancer screening because it detects hidden blood in stool before many patients develop symptoms. The category includes traditional guaiac fecal occult blood tests (gFOBT), high-sensitivity gFOBT, and fecal immunochemical tests (FIT), with FIT increasingly preferred in organized screening programs due to its human hemoglobin specificity, simplified sampling, and compatibility with quantitative laboratory workflows.

The public health rationale is firmly established. The World Health Organization’s International Agency for Research on Cancer reported through GLOBOCAN 2022 that colorectal cancer accounted for more than 1.9 million new cases and over 900,000 deaths worldwide, making it one of the most significant preventable cancer burdens. Screening guidance from the U.S. Preventive Services Task Force recommends colorectal cancer screening for adults aged 45 to 75, with annual FIT or high-sensitivity gFOBT among accepted stool-based options. These evidence-backed recommendations continue to support demand for accurate, accessible, and scalable fecal occult testing solutions.

Transformative Shifts in the Fecal Occult Testing Landscape

The fecal occult testing landscape is shifting from opportunistic, clinic-centered testing toward organized, population-based screening models designed to improve participation, equity, and follow-up colonoscopy completion. FIT has become a key enabler of this transition because it can be mailed, processed at scale, and integrated into digital reminder systems, reducing barriers associated with invasive first-line screening.

Healthcare systems are also raising expectations for test performance, traceability, and quality assurance. Laboratories and diagnostic manufacturers are responding with automated analyzers, barcoded collection devices, standardized cutoffs, and electronic reporting that support higher throughput and more consistent interpretation. At the same time, adoption is being shaped by earlier screening age recommendations, growing awareness of early-onset colorectal cancer, and payer emphasis on preventive care metrics.

Cumulative Impact of Artificial Intelligence on Fecal Occult Testing

Artificial intelligence is adding cumulative value across fecal occult testing programs by improving patient identification, outreach prioritization, logistics, result management, and follow-up adherence. AI-enabled analytics can mine electronic health records to identify screening-eligible adults, flag overdue patients, tailor outreach messages, and predict non-return of mailed kits, helping health systems close documented screening gaps.

AI also supports operational quality by forecasting kit demand, optimizing laboratory staffing, and monitoring abnormal result pathways to reduce delays between positive stool tests and diagnostic colonoscopy. While AI does not replace validated fecal occult blood detection chemistry or colonoscopy confirmation, its role in workflow orchestration is increasingly important. Responsible adoption requires transparent model validation, bias monitoring, cybersecurity controls, and compliance with applicable health data regulations such as HIPAA in the United States and GDPR in Europe.

Key Regional Insights Across Global Fecal Occult Testing

North America is a leading adoption environment for fecal occult testing due to mature preventive screening recommendations, insurance coverage for colorectal cancer screening, and widespread use of mailed FIT outreach in integrated delivery networks. The United States anchors regional demand through USPSTF-backed screening from age 45, while Canada’s provincial programs continue to rely heavily on FIT as a population-level screening tool.

Europe benefits from structured public health programs and European Union recommendations that support organized colorectal cancer screening, with FIT increasingly replacing older guaiac-based approaches in many national programs. Asia-Pacific is expanding as China, Japan, South Korea, Australia, and India respond to rising colorectal cancer incidence, urbanization, and broader preventive health initiatives. Latin America is advancing through public cancer control programs and improving diagnostic access, led by countries such as Brazil and Mexico. The Middle East is strengthening preventive health strategies through national transformation agendas and investment in laboratory infrastructure, while Africa presents important unmet screening needs, with adoption influenced by awareness, reimbursement, workforce capacity, and colonoscopy access after positive tests.

Key Group Insights Shaping Fecal Occult Testing Demand

Among major economic and policy groups, the G7 represents the most established environment for fecal occult testing commercialization due to high healthcare spending, mature laboratories, and formal colorectal cancer screening guidance. The European Union is notable for coordinated public health policy, cross-country quality assurance, and continued movement toward organized FIT-based screening.

BRICS countries represent a large-volume opportunity because of expanding middle-class populations, rising cancer awareness, and increasing public-sector investment in diagnostics, although screening infrastructure differs widely across China, India, Brazil, Russia, and South Africa. ASEAN markets are gaining momentum through healthcare modernization, expanding primary care access, and public-private diagnostic partnerships, while GCC countries are investing in preventive health programs aligned with national health transformation strategies. NATO membership itself is not a healthcare procurement framework, but many NATO countries overlap with high-income screening markets where laboratory automation, data security, interoperability, and resilient supply chains influence purchasing decisions.

Key Country Insights for Fecal Occult Testing Adoption

The United States remains one of the most influential fecal occult testing markets because national guidelines support stool-based colorectal cancer screening, quality measures incentivize screening completion, and large health systems use mailed FIT to reach eligible populations. Canada continues to advance FIT through provincial screening programs, while Mexico and Brazil show growing potential as cancer prevention policies, public awareness, and diagnostic access improve.

In Europe, the United Kingdom, Germany, France, Italy, and Spain rely on organized screening policies and laboratory networks that support broader FIT utilization, while Russia presents demand tied to cancer control priorities and regional healthcare capacity. China’s large eligible population, Japan’s long-standing screening culture, South Korea’s national screening infrastructure, Australia’s National Bowel Cancer Screening Program, and India’s expanding diagnostic sector make Asia-Pacific central to fecal occult testing adoption. These country-level dynamics show that adoption depends not only on test availability, but also on public awareness, sample return rates, laboratory automation, reimbursement pathways, and timely colonoscopy follow-up.

Actionable Recommendations for Fecal Occult Testing Leaders

Industry leaders should prioritize FIT-based portfolios that combine clinical accuracy, user-friendly sample collection, automated processing, and digital connectivity. Product strategies should emphasize validated sensitivity and specificity, stable sample handling, clear patient instructions, and seamless integration with laboratory information systems, electronic health records, and population health platforms.

Commercial teams should align with screening programs, payers, employers, and primary care networks to improve kit distribution and return rates. Manufacturers and service providers can differentiate by offering end-to-end solutions that include outreach analytics, multilingual patient education, logistics support, abnormal-result tracking, and quality dashboards. Leaders should also invest in regulatory readiness, cybersecurity, supply chain resilience, and evidence generation that demonstrates improved screening completion and reduced downstream colorectal cancer burden.

Research Methodology for Evidence-Based Market Analysis

This executive summary is based on a structured review of verified public health guidance, peer-reviewed clinical literature, and recognized institutional sources, including WHO/IARC GLOBOCAN data, U.S. Preventive Services Task Force colorectal cancer screening recommendations, American Cancer Society guidance, European screening policy documents, and national program materials where available.

The analysis evaluates fecal occult testing across technology type, screening workflow, regional adoption, policy environment, healthcare infrastructure, and digital transformation. Insights were synthesized through evidence triangulation, focusing on documented screening recommendations, cancer burden statistics, laboratory practice trends, and implementation factors that influence real-world adoption. No unsupported market-size estimates, market share statements, forecasts, or unverified claims are used.

Conclusion: The Future of Fecal Occult Testing

Fecal occult testing is positioned as a critical component of global colorectal cancer prevention because it is noninvasive, scalable, and supported by major screening guidelines. As healthcare systems move toward earlier detection and population-level outreach, FIT is expected to remain central to screening strategies due to its operational advantages and patient acceptability.

The next phase of adoption will be shaped by automation, digital engagement, AI-assisted workflow management, and stronger linkage between positive stool tests and diagnostic colonoscopy. Organizations that combine validated testing performance with accessible delivery models and data-driven program support will be best positioned to improve outcomes and strengthen long-term relevance in fecal occult testing.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fecal Occult Testing Market, by Test Type
7.1. Introduction
7.2. Guaiac Fecal Occult Blood Test
7.3. Fecal Immunochemical Test (FIT / iFOBT)
7.4. Immuno-FOB Variants
8. Fecal Occult Testing Market, by Test Method
8.1. Introduction
8.2. Qualitative
8.3. Quantitative
9. Fecal Occult Testing Market, by Sample Collection Method
9.1. Introduction
9.2. Laboratory-based
9.3. Point-of-care
9.4. Home Collection
10. Fecal Occult Testing Market, by Application
10.1. Introduction
10.2. Diagnostic
10.2.1. Routine Diagnosis
10.2.2. Symptom Based Diagnosis
10.3. Screening
10.3.1. Mass Screening
10.3.2. Opportunistic Screening
11. Fecal Occult Testing Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Centers
11.4. Hospitals
11.4.1. Large Hospitals
11.4.2. Small And Medium Hospitals
12. Fecal Occult Testing Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Fecal Occult Testing Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Fecal Occult Testing Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Bio-Rad Laboratories, Inc.
16.3. Cardinal Health
16.4. Cenogenics Corporation
16.5. CTK Biotech, Inc.
16.6. Danaher Corporation
16.7. Diagnostic Solutions Laboratory, LLC
16.8. DiaSorin S.p.A.
16.9. Eiken Chemical Co., Ltd.
16.10. Emes Software, LLC
16.11. Epitope Diagnostics Inc.
16.12. Geisinger Medical Laboratories
16.13. Genova Diagnostics Inc.
16.14. Helena Laboratories Corporation
16.15. Hologic Inc.
16.16. Lauriston Laboratories Ltd
16.17. Meridian Bioscience Inc.
16.18. Pinnacle BioLabs
16.19. Polymedco, LLC
16.20. QIAGEN N.V.
16.21. Quest Diagnostics
16.22. QuidelOrtho Corporation
16.23. ScheBo Biotech AG
16.24. Siemens Healthineers
List of Figures
FIGURE 1. GLOBAL FECAL OCCULT TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL FECAL OCCULT TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL FECAL OCCULT TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL FECAL OCCULT TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL FECAL OCCULT TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2025 VS 2032 (%)
FIGURE 9. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2025 VS 2032 (%)
FIGURE 11. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL FECAL OCCULT TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL FECAL OCCULT TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL FECAL OCCULT TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL GUAIAC FECAL OCCULT BLOOD TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL GUAIAC FECAL OCCULT BLOOD TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL GUAIAC FECAL OCCULT BLOOD TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL FECAL IMMUNOCHEMICAL TEST (FIT / IFOBT) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL FECAL IMMUNOCHEMICAL TEST (FIT / IFOBT) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL FECAL IMMUNOCHEMICAL TEST (FIT / IFOBT) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNO-FOB VARIANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNO-FOB VARIANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNO-FOB VARIANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL QUALITATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL QUALITATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL QUALITATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL QUANTITATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL QUANTITATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL QUANTITATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LABORATORY-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LABORATORY-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LABORATORY-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL POINT-OF-CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL POINT-OF-CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL POINT-OF-CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HOME COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HOME COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL HOME COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ROUTINE DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ROUTINE DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ROUTINE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SYMPTOM BASED DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SYMPTOM BASED DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SYMPTOM BASED DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MASS SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MASS SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MASS SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL OPPORTUNISTIC SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL OPPORTUNISTIC SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL OPPORTUNISTIC SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LARGE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL LARGE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL LARGE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SMALL AND MEDIUM HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SMALL AND MEDIUM HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SMALL AND MEDIUM HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 75. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 77. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 78. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 79. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 80. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 81. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 82. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 83. EUROPE FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 84. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 93. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 102. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 104. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 105. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 106. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 108. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 109. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. AFRICA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. NATO FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. NATO FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 123. NATO FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 124. NATO FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 125. NATO FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. NATO FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 127. NATO FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 128. NATO FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. NATO FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 130. G7 FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. G7 FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 132. G7 FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 133. G7 FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 134. G7 FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 135. G7 FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 136. G7 FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 137. G7 FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. G7 FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 139. BRICS FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. BRICS FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 141. BRICS FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 142. BRICS FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 143. BRICS FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. BRICS FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 145. BRICS FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 146. BRICS FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. BRICS FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 157. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 159. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 160. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 161. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 163. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 164. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. ASEAN FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 166. GCC FECAL OCCULT TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. GCC FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 168. GCC FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 169. GCC FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 170. GCC FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. GCC FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 172. GCC FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 173. GCC FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. GCC FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 176. CHINA FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 177. CHINA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 178. CHINA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 179. CHINA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 180. CHINA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. CHINA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 182. CHINA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 183. CHINA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. CHINA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 185. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 186. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 194. JAPAN FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 195. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 196. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 197. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 198. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 200. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 201. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 203. INDIA FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. INDIA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 205. INDIA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 206. INDIA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 207. INDIA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. INDIA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 209. INDIA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 210. INDIA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. INDIA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 212. GERMANY FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 213. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 214. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 215. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 216. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 218. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 219. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 230. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 232. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 233. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 234. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 236. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 237. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 239. FRANCE FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 241. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 242. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 243. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 245. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 246. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 248. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 250. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 251. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 254. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 255. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 257. ITALY FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. ITALY FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 259. ITALY FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 260. ITALY FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 261. ITALY FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. ITALY FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 263. ITALY FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 264. ITALY FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. ITALY FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 266. CANADA FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. CANADA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 268. CANADA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 269. CANADA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 270. CANADA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. CANADA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 272. CANADA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 273. CANADA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. CANADA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 275. RUSSIA FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 277. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 278. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 286. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 287. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 288. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 290. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 291. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 293. MEXICO FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 295. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 296. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 297. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 299. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 300. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 302. SPAIN FECAL OCCULT TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 304. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY TEST METHOD, 2017-2032 (USD MILLION)
TABLE 305. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY SAMPLE COLLECTION METHOD, 2017-2032 (USD MILLION)
TABLE 306. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY DIAGNOSTIC, 2017-2032 (USD MILLION)
TABLE 308. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY SCREENING, 2017-2032 (USD MILLION)
TABLE 309. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 311. GLOBAL FECAL OCCULT TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 312. GLOBAL FECAL OCCULT TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health
  • Cenogenics Corporation
  • CTK Biotech, Inc.
  • Danaher Corporation
  • Diagnostic Solutions Laboratory, LLC
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Emes Software, LLC
  • Epitope Diagnostics Inc.
  • Geisinger Medical Laboratories
  • Genova Diagnostics Inc.
  • Helena Laboratories Corporation
  • Hologic Inc.
  • Lauriston Laboratories Ltd
  • Meridian Bioscience Inc.
  • Pinnacle BioLabs
  • Polymedco, LLC
  • QIAGEN N.V.
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • ScheBo Biotech AG
  • Siemens Healthineers

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 918.36 Million
Forecasted Market Value ( USD ) by 2032 $ 1470 Million
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Fecal Occult Testing - Global Strategic Business Report - Product Image

Fecal Occult Testing - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
In-vitro Colorectal Cancer Screening Tests Market Size, Share, Trends and Forecast by Product, Imaging Type, End User, and Region, 2026-2034 - Product Image

In-vitro Colorectal Cancer Screening Tests Market Size, Share, Trends and Forecast by Product, Imaging Type, End User, and Region, 2026-2034

  • Report
  • 140 Pages
  • Global
From
Frequently Asked Questions About the India Fecal Occult Testing Market Research Report and Industry Forecast Report - Product Image

Frequently Asked Questions About the India Fecal Occult Testing Market Research Report and Industry Forecast Report

  • Report
  • 136 Pages
  • India
From
Fecal Occult Blood Test (FOBT) Global Market Report 2026 - Product Image

Fecal Occult Blood Test (FOBT) Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
GI Stool Testing - Global Strategic Business Report - Product Image

GI Stool Testing - Global Strategic Business Report

  • Report
  • 576 Pages
  • Global
From

About the Occult Blood Test Market

The Occult Blood Test (OBT) is a diagnostic test used to detect the presence of hidden blood in a patient's stool sample. It is used to detect gastrointestinal bleeding, which can be caused by a variety of conditions, including ulcers, colorectal cancer, and inflammatory bowel disease. OBTs are typically performed in a laboratory setting, and the results are used to help diagnose and monitor the progression of these conditions. OBTs are typically performed using a chemical reaction that causes a color change in the presence of blood. The test is relatively inexpensive and non-invasive, making it a popular choice for diagnosing gastrointestinal bleeding. OBT market players include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Becton Dickinson, and Sysmex Corporation. These companies offer a variety of OBT products, including test kits, reagents, and analyzers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.